Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.
Saved in:
| Title: | Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments. |
|---|---|
| Authors: | Steinhoff M; Department of Dermatology, UCD Charles Institute of Dermatology, University College Dublin, Dublin, Ireland. martin.steinhoff@ucd.ie.; Department of Dermatology, University of California, San Diego, CA, USA. martin.steinhoff@ucd.ie.; Department of Neurosciences, University of California, Davis, CA, USA. martin.steinhoff@ucd.ie., Vocanson M; CIRI, International Center for Infectiology Research, Université de Lyon, Lyon, France.; Inserm, U1111, Lyon, France., Voegel JJ; Galderma International S.A.S., Paris, France., Hacini-Rachinel F; Galderma International S.A.S., Paris, France., Schäfer G; Galderma International S.A.S., Paris, France. |
| Source: | Advances in therapy [Adv Ther] 2016 Sep; Vol. 33 (9), pp. 1481-501. Date of Electronic Publication: 2016 Jul 18. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27432381 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Steinhoff+M%22">Steinhoff M</searchLink>; Department of Dermatology, UCD Charles Institute of Dermatology, University College Dublin, Dublin, Ireland. martin.steinhoff@ucd.ie.; Department of Dermatology, University of California, San Diego, CA, USA. martin.steinhoff@ucd.ie.; Department of Neurosciences, University of California, Davis, CA, USA. martin.steinhoff@ucd.ie.<br /><searchLink fieldCode="AU" term="%22Vocanson+M%22">Vocanson M</searchLink>; CIRI, International Center for Infectiology Research, Université de Lyon, Lyon, France.; Inserm, U1111, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Voegel+JJ%22">Voegel JJ</searchLink>; Galderma International S.A.S., Paris, France.<br /><searchLink fieldCode="AU" term="%22Hacini-Rachinel+F%22">Hacini-Rachinel F</searchLink>; Galderma International S.A.S., Paris, France.<br /><searchLink fieldCode="AU" term="%22Schäfer+G%22">Schäfer G</searchLink>; Galderma International S.A.S., Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2016 Sep; Vol. 33 (9), pp. 1481-501. <i>Date of Electronic Publication: </i>2016 Jul 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27432381 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12325-016-0380-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1481 Titles: – TitleFull: Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Steinhoff M – PersonEntity: Name: NameFull: Vocanson M – PersonEntity: Name: NameFull: Voegel JJ – PersonEntity: Name: NameFull: Hacini-Rachinel F – PersonEntity: Name: NameFull: Schäfer G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2016 Sep Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1865-8652 Numbering: – Type: volume Value: 33 – Type: issue Value: 9 Titles: – TitleFull: Advances in therapy Type: main |
| ResultId | 1 |
